Science
Spectacles with highly aspherical lenslets for pre-myopia
In this article:
This randomized controlled trial explores early intervention and prevention of myopia by investigating the use of highly aspherical lenslet (HAL) spectacle lenses in pre-myopic children over a 1 year period. The first study to investigate optical treatment for pre-myopia, the findings indicate efficacy in children with low hyperopic reserves, with a dose-dependent effect.
Paper title: Spectacle lenses with highly aspherical lenslets for slowing axial elongation and refractive change in low-hyperopic Chinese children: a randomized controlled trial
Authors: Zhang, Zhe (1, 3, 4), Zeng, Li (1, 3, 4), Gu, Dantong (2), Wang, Bingjie (5), Kang, Pauline (5), Watt, Kathleen (5), Zhou, Jiaqi (1, 3, 4), Zhou, Xueyi (1, 3, 4), Chen, Zhuoyi (1, 3, 4), Yang, Danjuan (1, 3, 4), Chen, Can (1, 3, 4), Wang, Xiaoying (1, 3, 4), Zhou, Xingtao (1, 3, 4), Chen, Zhi (1, 3, 4)
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China
- Clinical Research and Achievement Translation Center, Eye & ENT Hospital, Fudan University, Shanghai, China
- NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China
- Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China
- School of Optometry and Vision Science, University of New South Wales, Sydney, Australia
Date: Aug 2024
Reference: Zhang Z, Zeng L, Gu D, Wang B, Kang P, Watt K, Zhou J, Zhou X, Chen Z, Yang D, Chen C, Wang X, Zhou X, Chen Z. Spectacle Lenses With Highly Aspherical Lenslets for Slowing Axial Elongation and Refractive Change in Low-Hyperopic Chinese Children: A Randomized Controlled Trial. Am J Ophthalmol. 2024 Aug 27;269:60-68.
Summary
There are a number of myopia control interventions which have demonstrated efficacy for reducing myopia progression in children. However, there is limited research into methods to delay the onset of myopia in children at high risk of becoming myopic. It is known that the biggest risk factor for developing myopia is being less hyperopic than age-normal,1 which in the current paper is termed ‘hyperopic reserve’. The impact of preventing myopia in children with low hyperopic reserve is significant, with the reduction in the final level of myopia being potentially greater when delaying myopia onset by one year, compared to the effect of 2-3 years of myopia control treatment in already myopic children.2 As for preventive measures for pre-myopic children, the options are limited - with only outdoor time and low-dose atropine (0.01%, 0.025% and 0.05%) previously explored in controlled clinical trials.3-7
This study investigated the efficacy of spectacle lenses with highly aspherical lenslets (HAL) as an intervention for slowing axial elongation and myopia development in children with low hyperopic reserve. 108 Chinese children aged 6 to less than 10 years, with spherical equivalent refractive error 0.00 to +2.00 D, were randomly assigned either HAL or single vision lens (SVL) spectacles to wear at least 5 days per week and at least 4 hours per day. All lenses were prescribed with 0.00 dioptres. Cycloplegic refraction, axial length (AL), and uncorrected visual acuity were measured at baseline, 6 and 12 months after dispensing. The results were as follows.
- The mean age of each group was 7.0 years. In the treatment group, the mean refraction was +0.48D and axial length (AL) 22.80mm.
- Across the whole group, the 1-year AL elongation was 0.24 mm and 0.19 mm in the SVL and HAL groups, respectively. The 1-year change in spherical equivalent refraction (SERE) was -0.19 D and -0.23 D in the SVL and HAL groups, respectively. Neither of these differences were statistically significant. The mean wearing time was around 30 hours per week, assessed through both a subjective survey and objective ‘Clouclip’ device (attached to spectacle frame) data.
- A sub-group analysis of younger (6 to 7.9 years) versus older (8 to 9.9 years) children, and by level of hyperopic reserve (0.00 to +1.00D versus +1.00 to +2.00D) found no significant interactions, indicating no specifically ‘better’ candidates for this treatment.
There was a clear relationship between increased wearing time and smaller changes in AL and SERE. Wearing spectacle lenses with HAL for at least 30 hours per week (exceeding the mean wearing time) significantly reduced AL elongation, with 0.11mm growth in one year compared to 0.27mm in SVL wearers. The refraction difference of 0.27D wasn’t statistically significant, but the axial length difference was. This relationship between wearing time and slower progression was not found in the SVL wearers.
What does this mean for my practice?
HAL spectacles utilise a novel optical design that has been established to be effective in controlling axial elongation and myopic progression in already myopic children.8 This data shows that children with low ‘hyperopic reserve’, or pre-myopia, who are therefore at higher risk of developing myopia, can also potentially benefit from this treatment, provided longer wearing hours (at least 30 hours/week) are achieved. HAL spectacles could potentially be a safer alternative to atropine due to the lack of side effects, although the long-term effect in attempting to delay myopia onset is not yet known.
What do we still need to learn?
This study is the first to explore the use of optical interventions to delay myopia onset, therefore providing valuable insight into the viability of myopia control in pre-myopic children. This raises questions as to whether other myopic control spectacle or even contact lens designs, can achieve a similar treatment efficacy.
This study was undertaken in Chinese children, aged 6 to less than 10 years, with cycloplegic refractions from plano to +2.00D. A previous study in this population has shown that a ‘hyperopic reserve’ of at least +1.50D was required to offset myopia onset risk within a mean 1.3 years of follow up, regardless of age.9 Another recent Chinese study cited the ‘mean hyperopic reserve’ as 2.08D at 6 years, 1.49D at 8 years and 1.04D at 10 years.10
By contrast, the well-known CLEERE study in North America (36% White, 22% Hispanic) cited +0.75D as the cut-off for myopia risk in children aged 6 years, with lower ‘hyperopic reserve’ for older children.1 This raises the question of what level of ‘hyperopic reserve’ is required to reduce myopia onset risk, based on age and ethnicity – fine-tuning the definition of pre-myopia.
While this is promising for the utility of HAL spectacles, longer studies are required to determine whether the treatment shows sustained efficacy and even whether the development of myopia can be prevented. Similar investigations should be conducted in other regions of the world, and studies consisting of multiple centers and larger study populations are warranted to improve the generalizability of results to other populations.
Abstract
Title: Spectacle lenses with highly aspherical lenslets for slowing axial elongation and refractive change in low-hyperopic Chinese children: a randomized controlled trial
Authors: Zhang, Zhe, Zeng, Li, Gu, Dantong, Wang, Bingjie, Kang, Pauline, Watt, Kathleen, Zhou, Jiaqi, Zhou, Xueyi, Chen, Zhuoyi, Yang, Danjuan, Chen, Can, Wang, Xiaoying, Zhou, Xingtao, Chen, Zhi
Purpose: Spectacle lenses with highly aspherical lenslets (HAL) have been shown to effectively retard myopia progression in myopic children. This study aimed to investigate the impact of spectacle lenses with HAL on refractive and axial length (AL) changes in Chinese children with low amount of hyperopia.
Methods: A total of 108 Chinese children aged 6.0 to 9.9 years and spherical equivalent refractive error (SERE) from 0.00 to +2.00 D were randomly allocated into two groups: the HAL group and the single vision spectacle lens (SVL) group. Cycloplegic refraction, AL, and uncorrected visual acuity were measured at baseline, 6 and 12 months after lens dispensing. The duration of spectacle lens wear was monitored using a wearable device attached to the spectacle frame and by questionnaire logs provided by participants at each follow-up visit.
Results: The 1-year SERE change was -0.19 (-0.32, 0.03) D and -0.23 (-0.36, 0.05) D in the SVL and HAL groups (P = .883). The 1-year AL elongation was 0.24 (0.18, 0.34) mm and 0.19 (0.12, 0.27) mm in the SVL and HAL groups (P = .057). In the HAL group, changes in AL and SERE were significantly correlated to lens wearing time (P < .001 and P = .024, respectively). Participants in the HAL group who wore their lenses for more than 30 hours per week had significantly slower AL elongation (0.11 [0.05, 0.17] mm) compared to their SVL counterparts (0.27 [0.21, 0.33] mm) (P < .001).
Conclusions: Spectacle lenses with HAL significantly reduced AL elongation in low hyperopic children who wore lenses for over 30 hours per week. A dose-response relationship was evident with longer lens wearing time associated with less AL change.
Meet the Authors:
About Brian Peng
Brian is a clinical optometrist based in Sydney, Australia. He graduated with a Master of Clinical Optometry from the University of New South Wales in 2020.
Read Brian's work on our My Kids Vision website, our public awareness platform. Brian also works on development of various new resources across MyopiaProfile.com.
References
- Zadnik K, Sinnott LT, Cotter SA, Jones-Jordan LA, Kleinstein RN, Manny RE, Twelker JD, Mutti DO; Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study Group. Prediction of Juvenile-Onset Myopia. JAMA Ophthalmol. 2015 Jun;133(6):683-9.
- Bullimore MA, Brennan NA. Myopia: An ounce of prevention is worth a pound of cure. Ophthalmic Physiol Opt. 2023 Jan;43(1):116-121.
- French AN, Ashby RS, Morgan IG, Rose KA. Time outdoors and the prevention of myopia. Exp Eye Res. 2013 Sep;114:58-68.
- Jethani J. Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes. Indian J Ophthalmol. 2022 Jan;70(1):238-240.
- Wang W, Zhang F, Yu S, Ma N, Huang C, Wang M, Wei L, Zhang J, Fu A. Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial. Eur J Pediatr. 2023 Jun;182(6):2597-2606.
- Fang PC, Chung MY, Yu HJ, Wu PC. Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocul Pharmacol Ther. 2010 Aug;26(4):341-5.
- Yam JC, Zhang XJ, Zhang Y, Yip BHK, Tang F, Wong ES, Bui CHT, Kam KW, Ng MPH, Ko ST, Yip WWK, Young AL, Tham CC, Chen LJ, Pang CP. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA. 2023 Feb 14;329(6):472-481.
- Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, Wang C, Li Y, Lim EW, Spiegel DP, Drobe B, Chen H. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. 2022 May 1;140(5):472-478.
- Chen Z, Gu D, Wang B, Kang P, Watt K, Yang Z, Zhou X. Significant myopic shift over time: Sixteen-year trends in overall refraction and age of myopia onset among Chinese children, with a focus on ages 4-6 years. J Glob Health. 2023 Nov 9;13:04144.
- Wang J, Qi Z, Feng Y, Chen J, Du L, Yang J, Xie H, Zhu J, Zou H, He X, Xu X. Normative value of hyperopia reserve and myopic shift in Chinese children and adolescents aged 3-16 years. Br J Ophthalmol. 2024 Jun 20;108(7):1024-1029.
Enormous thanks to our visionary sponsors
Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.